EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A novel bispecific antibody targeting TNF-α and IL-6 receptor as a potent immunotherapeutic agent for inflammation

Mansooreh Heravi, Shadi Damough, Ladan Mafakher, Yeganeh Talebkhan, Leila Nematollahi, Leila Ghazizadeh, Soheila Ajdari

Applied Microbiology and Biotechnology · 09.10.2025 · 109 (1)

DOI: 10.1007/s00253-025-13596-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift Applied Microbiology and Biotechnology, online erschienen am 09.10.2025. Verfasst von Mansooreh Heravi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran. Hauptthemen laut MEDLINE: Antibodies, Bispecific, Tumor Necrosis Factor-alpha, Receptors, Interleukin-6, Inflammation. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Pasteur Institute of Iran.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, BispecificTumor Necrosis Factor-alphaReceptors, Interleukin-6InflammationHumansAntibodies, Monoclonal, HumanizedMolecular Docking SimulationSTAT3 Transcription FactorRecombinant ProteinsEscherichia coliAdalimumabImmunotherapyInterleukin-6PhosphorylationMolecular Dynamics Simulation

Stichwörter der Autor:innen

Bispecific antibodyIL-6 receptorRheumatoid arthritisTumor necrosis factor (TNF-α)

Substanzen

Antibodies, BispecificTumor Necrosis Factor-alphaReceptors, Interleukin-6Antibodies, Monoclonal, HumanizedtocilizumabSTAT3 Transcription FactorRecombinant ProteinsAdalimumabInterleukin-6

Autor:innen und Institutionen

  • Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran.
  • Thalassemia & Hemoglobinopathy Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. mafakher.l@ajums.ac.ir.
  • Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran. talebkhan@pasteur.ac.ir.
  • Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran. nematollahi@pasteur.ac.ir.
  • Cell Bank Department, Pasteur Institute of Iran, Tehran, Iran.
  • Immunology Department, Pasteur Institute of Iran, Tehran, Iran.

Förderung

  • Pasteur Institute of Iran

Zitieren

APA

Heravi, M., Damough, S., Mafakher, L., Talebkhan, Y., Nematollahi, L., Ghazizadeh, L., & Ajdari, S. (2025). A novel bispecific antibody targeting TNF-α and IL-6 receptor as a potent immunotherapeutic agent for inflammation. Applied Microbiology and Biotechnology, 109(1). https://doi.org/10.1007/s00253-025-13596-x

Vancouver

Heravi M, Damough S, Mafakher L, Talebkhan Y, Nematollahi L, Ghazizadeh L, et al. A novel bispecific antibody targeting TNF-α and IL-6 receptor as a potent immunotherapeutic agent for inflammation. Applied Microbiology and Biotechnology. 2025;109(1). doi:10.1007/s00253-025-13596-x

BibTeX
@article{Heravi2025,
  author = {Heravi, Mansooreh and Damough, Shadi and Mafakher, Ladan and Talebkhan, Yeganeh and Nematollahi, Leila and Ghazizadeh, Leila and Ajdari, Soheila},
  title = {A novel bispecific antibody targeting TNF-α and IL-6 receptor as a potent immunotherapeutic agent for inflammation},
  journal = {Applied Microbiology and Biotechnology},
  year = {2025},
  volume = {109},
  number = {1},
  doi = {10.1007/s00253-025-13596-x}
}
Kostenlos starten →